Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The GOLIATH Project: Towards an Internationally Harmonised Approach for Testing Metabolism Disrupting Compounds
Juliette Legler, Daniel Zalko, Fabien Jourdan, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 10, pp. 3480-3480
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Endocrine Disrupting Chemicals’ Effects in Children: What We Know and What We Need to Learn?
Barbara Predieri, Lorenzo Iughetti, Sergio Bernasconi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11899-11899
Open Access | Times Cited: 46
G protein-coupled estrogen receptor activation by bisphenol-A disrupts the protection from apoptosis conferred by the estrogen receptors ERα and ERβ in pancreatic beta cells
Ignacio Babiloni-Chust, Reinaldo S. Dos Santos, Regla M. Medina-Gali, et al.
Environment International (2022) Vol. 164, pp. 107250-107250
Open Access | Times Cited: 32
Xenobiotic-Induced Aggravation of Metabolic-Associated Fatty Liver Disease
Julie Massart, Karima Begriche, Anne Corlu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1062-1062
Open Access | Times Cited: 31
A vision for safer food contact materials: Public health concerns as drivers for improved testing
Jane Muncke, Anna‐Maria Andersson, Thomas Backhaus, et al.
Environment International (2023) Vol. 180, pp. 108161-108161
Open Access | Times Cited: 20
Endocrine disruptors in plastics alter β-cell physiology and increase the risk of diabetes mellitus
Juan Martínez‐Pinna, Roberto Sempere-Navarro, Regla M. Medina-Gali, et al.
AJP Endocrinology and Metabolism (2023) Vol. 324, Iss. 6, pp. E488-E505
Open Access | Times Cited: 18
Emerging concepts and opportunities for endocrine disruptor screening of the non-EATS modalities
Christopher J. Martyniuk, Rubén Martínez, Laia Navarro‐Martín, et al.
Environmental Research (2021) Vol. 204, pp. 111904-111904
Open Access | Times Cited: 39
Obesity III: Obesogen assays: Limitations, strengths, and new directions
Christopher D. Kassotis, Frederick S. vom Saal, Patrick J. Babin, et al.
Biochemical Pharmacology (2022) Vol. 199, pp. 115014-115014
Open Access | Times Cited: 27
Application of In Vitro Models for Studying the Mechanisms Underlying the Obesogenic Action of Endocrine-Disrupting Chemicals (EDCs) as Food Contaminants—A Review
Monika Kowalczyk, Jakub P. Piwowarski, Artur Wardaszka, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1083-1083
Open Access | Times Cited: 15
Development of new approach methods for the identification and characterization of endocrine metabolic disruptors—a PARC project
Albert Braeuning, Patrick Balaguer, William Bourguet, et al.
Frontiers in Toxicology (2023) Vol. 5
Open Access | Times Cited: 13
Endocrine disrupting chemicals and metabolic disorders in the liver: What if we also looked at the female side?
Brigitte Le Magueresse‐Battistoni
Chemosphere (2020) Vol. 268, pp. 129212-129212
Open Access | Times Cited: 34
Endocrine Disrupting Chemicals: Current Understanding, New Testing Strategies and Future Research Needs
Maria Elisabeth Street, Karine Audouze, Juliette Legler, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 2, pp. 933-933
Open Access | Times Cited: 29
Dysregulation of adipogenesis and disrupted lipid metabolism by the antidepressants citalopram and sertraline
Deniz Bozdağ, Jeroen van Voorthuizen, Nikita L. Korpel, et al.
Toxicology and Applied Pharmacology (2024) Vol. 486, pp. 116937-116937
Open Access | Times Cited: 4
Impact of Endocrine Disruptors on Key Events of Hepatic Steatosis in HepG2 Cells
M Grosso, Eliška Řehůřková, Ishita Virmani, et al.
Food and Chemical Toxicology (2025), pp. 115241-115241
Closed Access
Endocrine disrupting chemicals: strategies to protect present and future generations
Laura N. Vandenberg
Expert Review of Endocrinology & Metabolism (2021) Vol. 16, Iss. 3, pp. 135-146
Closed Access | Times Cited: 26
In Vitro Assays to Identify Metabolism-Disrupting Chemicals with Diabetogenic Activity in a Human Pancreatic β-Cell Model
Reinaldo S. Dos Santos, Regla M. Medina-Gali, Ignacio Babiloni-Chust, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 5040-5040
Open Access | Times Cited: 18
Innovative tools and methods for toxicity testing within PARC work package 5 on hazard assessment
Thalia De Castelbajac, Kiara Aiello, Celia Garcia Arenas, et al.
Frontiers in Toxicology (2023) Vol. 5
Open Access | Times Cited: 10
Avoiding a reproducibility crisis in regulatory toxicology—on the fundamental role of ring trials
Miriam N. Jacobs, Sebastian Hoffmann, Heli M. Hollnagel, et al.
Archives of Toxicology (2024) Vol. 98, Iss. 7, pp. 2047-2063
Open Access | Times Cited: 3
The Effects of Citalopram and Sertraline on Adipogenesis and Lipogenesis in 3T3-L1 Cells
Deniz Bozdağ, Bita Entezari, Hande Gürer-Orhan
Toxicology Letters (2025)
Closed Access
Using transcriptomics data and adverse outcome pathway networks to explore endocrine disrupting properties of Cadmium and PCB-126
Linus Wiklund, Emma Wincent, Anna Beronius
Environment International (2025) Vol. 197, pp. 109352-109352
Open Access
Reproducibility of adipogenic responses to metabolism disrupting chemicals in the 3T3-L1 pre-adipocyte model system: An interlaboratory study
Christopher D. Kassotis, Kate Hoffman, Johannes Völker, et al.
Toxicology (2021) Vol. 461, pp. 152900-152900
Open Access | Times Cited: 23
Highlighting the gaps in hazard and risk assessment of unregulated Endocrine Active Substances in surface waters: retinoids as a European case study
Barbara Kubíčková, Carmel Ramwell, Klára Hilscherová, et al.
Environmental Sciences Europe (2021) Vol. 33, Iss. 1
Open Access | Times Cited: 16
A modular strategy for the testing and assessment of non-genotoxic carcinogens
Kimmo Louekari, Miriam N. Jacobs
Archives of Toxicology (2024) Vol. 98, Iss. 8, pp. 2463-2485
Open Access | Times Cited: 2
Weight of evidence evaluation of the metabolism disrupting effects of triphenyl phosphate using an expert knowledge elicitation approach
Claire Beausoleil, Anne Thébault, Patrik L. Andersson, et al.
Toxicology and Applied Pharmacology (2024) Vol. 489, pp. 116995-116995
Open Access | Times Cited: 2
Addressing chemically-induced obesogenic metabolic disruption: selection of chemicals for in vitro human PPARα, PPARγ transactivation, and adipogenesis test methods
Eren Ozcagli, Barbara Kubíčková, Miriam N. Jacobs
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 2
High throughput screening of bisphenols and their mixtures under conditions of low-intensity adipogenesis of human mesenchymal stem cells (hMSCs)
Kalle Norgren, Astrud R. Tuck, Antero Vieira Silva, et al.
Food and Chemical Toxicology (2022) Vol. 161, pp. 112842-112842
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top